Table: Fuji Pharmaceutical -2021/22 parent results

Fuji Pharma

10/11/2022 08:00

Nov 10 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Sep 30, 2022    Sep 30, 2021   Sep 30, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           32.55           31.86          39.90        18.37    
               (+2.2 pct)      (+1.9 pct)     (+22.6 pct)  (+12.6 pct) 
  Operating        3.45            3.37           3.81         1.81    
               (+2.4 pct)      (+16.1 pct)    (+10.3 pct)  (-30.3 pct) 
  Recurring        3.40            3.32           3.85         1.83    
               (+2.3 pct)      (+18.2 pct)    (+13.4 pct)  (-34.0 pct) 
  Net              2.48            2.55           2.83         1.34    
               (-2.9 pct)      (+26.7 pct)    (+14.1 pct)  (-24.3 pct) 
  EPS          102.10 yen       95.10 yen     116.45 yen    55.32 yen  
  Ann Div       35.00 yen       29.00 yen      37.00 yen               
  -Q2 Div       15.00 yen       14.00 yen      17.00 yen               
  -Q4 Div       20.00 yen       15.00 yen      20.00 yen               
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T